INSM Q2 2020 Earnings — Insmed Incorporated Revenue & Financial Results | Market Cap Arena

INSMInsmed Incorporated

$30B

Q2 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$42M+41.8% YoY

Gross Profit

$33M76.6% margin

Operating Income

-$54M-127.3% margin

Net Income

-$62M-145.6% margin

EPS (Diluted)

$-0.64

QoQ Revenue Growth

+15.3%

Cash Flow

Operating Cash Flow

-$36M

Free Cash Flow

-$38M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$885M

Total Liabilities

$480M

Stockholders' Equity

$405M

Cash & Equivalents

$642M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$42M	$30M	+41.8%
Gross Profit	$33M	$25M	+29.9%
Operating Income	-$54M	-$62M	+13.0%
Net Income	-$62M	-$67M	+7.0%